A new law might let grown-ups in Florida use a plant called marijuana for fun. This could make some people a lot of money by 2025, around $874 million. Read from source...

1. The headline is misleading and sensationalist, implying that legal adult-use marijuana will generate $874 million in 2025, but not specifying where or how this figure was obtained or what assumptions were made. This creates a false impression of certainty and accuracy, which may influence investors' decisions without proper justification.

1. Trulieve Cannabis (OTC:TCNNF) - Strong buy with a target price of $50 per share by the end of 2024. The company has a dominant market position in Florida, with over 90% market share in the medical cannabis sector and a growing presence in other states. Trulieve also benefits from its low-cost production, diversified product portfolio, and strategic partnerships.
2. Curaleaf Holdings (CURLF) - Moderate buy with a target price of $15 per share by the end of 2024. The company is one of the largest vertically integrated cannabis operators in the U.S., with operations in several key markets, including Florida, Massachusetts, and Pennsylvania. Curaleaf has a strong balance sheet, a robust pipeline of acquisitions, and significant exposure to the potential adult-use market in Florida.
3. Liberty Health Sciences (LHSIF) - Speculative buy with a target price of $5 per share by the end of 2024. The company has a small but growing presence in Florida's medical cannabis market, with plans to expand its cultivation and distribution facilities. Liberty also has a strategic partnership with Aphria (APHA), one of the largest Canadian cannabis producers, which provides access to additional capital and resources.
4. Cresco Labs (CRLBF) - Moderate buy with a target price of $12 per share by the end of 2024. The company is one of the leading vertically integrated cannabis operators in the U.S., with operations in several states, including Illinois, Pennsylvania, and Florida. Cresco has a strong track record of growth, profitability, and expansion, as well as a focus on social equity and responsible business practices.
5. Green Thumb Industries (GTBIF) - Strong buy with a target price of $20 per share by the end of 2024. The company is one of the largest and most diversified cannabis operators in the U.S., with operations in 13 states and Puerto Rico, including Florida. Green Thumb has a dominant market position in several key markets, a robust pipeline of new store openings, and a strong balance sheet to support its growth initiatives.

Risks:

- The legalization of adult-use marijuana in Florida is not guaranteed, as Amendment 3 faces a challenging political environment and potential legal hurdles. Investors should monitor the progress of the amendment and its implementation by the state regulators.
- The cannabis industry is subject to rapid changes in regulations, laws,